At the same time, we detected the activity of Caspase 3 by ELISA, and the results also confirmed that there was no significant change in the activity of Caspase 3 in thyroid cancer cell lines after KA treatment (Fig. 4C). The gene discussed is CASP3; the disease is thyroid gland carcinoma.